Published June 28, 2016 | Version Supplemental Material
Journal Article Open

Fabrication of Sealed Nanostraw Microdevices for Oral Drug Delivery

  • 1. ROR icon University of California, San Francisco
  • 2. ROR icon Stanford University
  • 3. ROR icon University of California, Berkeley

Abstract

The oral route is preferred for systemic drug administration and provides direct access to diseased tissue of the gastrointestinal (GI) tract. However, many drugs have poor absorption upon oral administration due to damaging enzymatic and pH conditions, mucus and cellular permeation barriers, and limited time for drug dissolution. To overcome these limitations and enhance oral drug absorption, micron-scale devices with planar, asymmetric geometries, termed microdevices, have been designed to adhere to the lining of the GI tract and release drug at high concentrations directly toward GI epithelium. Here we seal microdevices with nanostraw membranes—porous nanostructured biomolecule delivery substrates—to enhance the properties of these devices. We demonstrate that the nanostraws facilitate facile drug loading and tunable drug release, limit the influx of external molecules into the sealed drug reservoir, and increase the adhesion of devices to epithelial tissue. These findings highlight the potential of nanostraw microdevices to enhance the oral absorption of a wide range of therapeutics by binding to the lining of the GI tract, providing prolonged and proximal drug release, and reducing the exposure of their payload to drug-degrading biomolecules.

Additional Information

© 2016 American Chemical Society. Received: February 1, 2016; Accepted: June 7, 2016; Published: June 7, 2016. C.B.F. was supported by NIH Training Grant 5T32GM007175-37 and an ARCS Fellowship. Y.C. was supported by Grant 70NANB15H192 from the U.S. Department of Commerce, National Institute of Standards and Technology. C.L.N. was supported by NSF Graduate Research Fellowship DGE-1106400. R.W.C. was supported by NIH Training Grant 5T32DK007762-38. A.M.X. was supported by NSF Graduate Fellowship DGE-114747 and an NDSEG Fellowship. This work was partially supported by NIH grant R01EB018842. We gratefully acknowledge use of the Carl Zeiss Ultra FE-SEM at San Francisco State University for all SEM imaging. The FE-SEM and supporting facilities were obtained under NSF-MRI award no. 0821619 and NSF-EAR award no. 0949176. Confocal fluorescence imaging was conducted at the Nikon Imaging Center, UCSF. Nanostraw membrane fabrication was performed the Stanford Nano Shared Facilities. Remaining fabrication was performed at the UCSF Biomedical Micro & Nanotechnology Core and UC Berkeley Biomolecular Nanotechnology Center. The authors would like to thank Colin Zamecnik, Margaret Lowe, and Jessie Lee for providing mouse tissue for the ex vivo experiments. The authors declare no competing financial interest.

Attached Files

Supplemental Material - nn6b00809_si_001.pdf

Files

nn6b00809_si_001.pdf

Files (986.0 kB)

Name Size
md5:159458ce56ef24fcf7c2a7cd07a8e262
986.0 kB Preview Download

Additional details

Identifiers

Eprint ID
69388
Resolver ID
CaltechAUTHORS:20160802-105817297

Funding

NIH Predoctoral Fellowship
5T32GM007175-37
Australian Research Council
National Institute of Standards and Technology (NIST)
70NANB15H192
NSF Graduate Research Fellowship
DGE-1106400
NIH Predoctoral Fellowship
5T32DK007762-38
NSF Graduate Research Fellowship
DGE-114747
National Defense Science and Engineering Graduate (NDSEG) Fellowship
NIH
R01EB018842
NSF
MRI-0821619
NSF
EAR-0949176

Dates

Created
2016-08-02
Created from EPrint's datestamp field
Updated
2021-11-11
Created from EPrint's last_modified field